These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7290257)

  • 1. The identification of Thormählen positive melanogen "A" from the urine of melanoma patients as 6-methoxy-5-indolylglucosiduronate.
    Matous B; Budĕsínská A; Budĕsínský M; Duchon J; Pavel S
    Neoplasma; 1981; 28(3):271-4. PubMed ID: 7290257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Thormählen-positive compound "B" in urine of patients with malignant melanoma.
    Pavel S; Boverhof R; van der Slik W
    Arch Dermatol Res; 1984; 276(3):156-9. PubMed ID: 6548107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the excretion of different types of melanogens in the melanoma patients.
    Matous B; Pavel S; Budĕsínská A; Duchon J; Mechl Z; Sopková B
    Neoplasma; 1979; 26(5):597-602. PubMed ID: 118388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromatography of melanogens from urine of hamsters with transplantable melanoms. I. Thormählen-positive melanogens.
    Pavel S; Schwippelová Z; Duchon J; Matous B; Vulterin K
    J Chromatogr; 1978 Jul; 154(1):117-21. PubMed ID: 670364
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of two Thormählen-positive compounds from melanotic urine by gas chromatography-mass spectrometry.
    Pavel S; Muskiet FA; Nagel GT; Schwippelová Z; Duchon J
    J Chromatogr; 1981 Mar; 222(3):329-36. PubMed ID: 7228942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical significance of tests for Thormählen-positive melanogen excretion in malignant melanoma].
    Matous B; Budĕsínská A; Mechl Z; Sopková B; Pavel S; Duchon J
    Cesk Dermatol; 1980 Aug; 55(4):238-41. PubMed ID: 7407958
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of 5-hydroxy-6-indolyl-O-sulfate in urine of patients with malignant melanoma.
    Pavel S; Boverhof R; Wolthers BG
    J Invest Dermatol; 1984 Jun; 82(6):577-9. PubMed ID: 6547157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Hydroxy-6-methoxy-2-indolylcarboxylic and 6-hydroxy-5-methoxy-2-indolylcarboxylic acids in the urine of hamsters with melanotic melanoma.
    Pavel S; Matous B; Duchon J; Bubnová E
    Neoplasma; 1978; 25(3):343-7. PubMed ID: 683376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Increased excretion of indolemelanogens in malignant melanoma without liver metastasis].
    Schwartze G; Haneke E
    Dermatol Monatsschr; 1969; 155(2):99-102. PubMed ID: 5386292
    [No Abstract]   [Full Text] [Related]  

  • 10. Melanogenuria: laboratory evaluation of the qualitative Thormählen and ferric chloride tests and their clinical utility.
    Scott RE; Ward VL; Grinstead GF; Stevens BS; Wilson DM
    Clin Chem; 1988 Mar; 34(3):582-5. PubMed ID: 3349611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Quantitative melanin demonstration in melanoma carriers in different stages].
    Kühne KH; Warnecke R; Bauermann D
    Dermatol Monatsschr; 1970; 156(5):367-70. PubMed ID: 5509134
    [No Abstract]   [Full Text] [Related]  

  • 12. [Annual rhythm of the excretion of indole melanogen in human urine].
    Schwartze G
    Arch Geschwulstforsch; 1988; 58(5):341-4. PubMed ID: 3202684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interference of urinalysis through indole-melanogens].
    Kutter D; Humbel R; Hertz S
    Med Lab (Stuttg); 1978 Aug; 31(8):194-200. PubMed ID: 683124
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of 5,6-dimethoxyindolyl-2-carboxylic acid in melanotic urine.
    Pavel S; Elzinga H; Muskiet FA; Wolthers BG
    Acta Derm Venereol; 1983; 63(4):340-3. PubMed ID: 6195867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromatography of melanogens from urine of hamsters with transplantable melanoma. II. Thormählen-negative melanogens.
    Schwippelová Z; Pavel S; Duchon J; Matous B
    J Chromatogr; 1978 Jul; 154(1):122-6. PubMed ID: 670365
    [No Abstract]   [Full Text] [Related]  

  • 16. A qualitative gas chromatographic analysis of substituted 5,6-dihydroxyindoles from the urine of patients with melanoma.
    Pavel S; Muskiet FA; Budesínská A; Duchon J
    Tumori; 1981 Aug; 67(4):325-32. PubMed ID: 6797117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eumelanin-related indolic compounds in the urine of treated melanoma patients.
    Pavel S; Elzinga H; Muskiet FA; Smit JM; Mulder NH; Koops HS
    J Clin Chem Clin Biochem; 1986 Mar; 24(3):167-73. PubMed ID: 3711799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excretion of melanogens and zinc during the growth of melanoma in hamsters.
    Horcicko J; Pavel S; Borovanský J; Duchon J
    Neoplasma; 1979; 26(4):471-5. PubMed ID: 522918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Data processing of urine chromatograms for the clinical management of melanoma.
    Banda PW; Tuttle MS; Selmer LE; Thatachari YT; Sherry AE; Blois MS
    Comput Biomed Res; 1980 Dec; 13(6):549-66. PubMed ID: 6780261
    [No Abstract]   [Full Text] [Related]  

  • 20. Eumelanin (precursor) metabolites as markers for pigmented malignant melanoma: a preliminary report.
    Pavel S; Muskiet FA
    Cancer Detect Prev; 1983; 6(1-2):311-6. PubMed ID: 6883388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.